Close this search box.
Close this search box.

Mofecon 500

Mofecon 500

Mofecon 500 characteristics

Therapeutic classificationSelective immunosuppressant
BrandMofecon 500
CompoundsMycophenolate Mofetil
Dosage formtablet
 Dosage strength500 mg
Package60 tablet
Produced byConcord Biotech / India
Indicationprevent organ rejection in patients who are at least three months of age who have received a liver transplant, a heart transplant, or a kidney transplant.
Mechanism of actionMycophenolate is a prodrug of mycophenolic acid (MPA), an inhibitor of inosine-5′-monophosphate dehydrogenase. MPA depletes guanosine nucleotides preferentially in T and B lymphocytes and inhibits their proliferation, thereby suppressing cell-mediated immune responses and antibody formation.
Use in pregnancy and breastfeedingD in pregnancy

Information on the use of mycophenolate while breastfeeding is very limited. Be sure talk to your healthcare provider about all of your breastfeeding questions.

PrecautionsThe most common side effects of taking MOFECON 500MG TABLET are nausea, vomiting, diarrhea, stomach pain, headache, high blood pressure, and low number of white blood cells.
Drug interactionsother drugs that weaken the immune system/increase the risk of infection (such as natalizumab, rituximab).

Mycophenolate may decrease the excretion rate of Abacavir, could result in a higher serum level.

Superior features FDA approved

BE study